feed,title,long_url,short_url
MedRxiv,"An open label, adaptive, phase 1 trial of high-dose oral nitazoxanide in healthy volunteers: an antiviral candidate for SARS-CoV-2",https://medrxiv.org/cgi/content/short/2021.09.10.21263376v1?rss=1,https://j.mp/3hqASkt
MedRxiv,The anticipated artificial increase in life expectancy from COVID-19,https://medrxiv.org/cgi/content/short/2021.09.09.21263351v1?rss=1,https://j.mp/3Eb6S64
